002932 明德生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.2371.2571.19690.61472.648
总资产报酬率 ROA (%)0.2131.0660.90466.73958.353
投入资产回报率 ROIC (%)0.2331.2321.13484.56867.585

边际利润分析
销售毛利率 (%)32.31153.89154.27866.84675.015
营业利润率 (%)-7.56011.76619.37148.24059.997
息税前利润/营业总收入 (%)-3.0536.53019.35647.87659.674
净利润/营业总收入 (%)-5.4887.5899.23541.60051.123

收益指标分析
经营活动净收益/利润总额(%)2,017.257-254.38521.010118.847100.883
价值变动净收益/利润总额(%)-1,395.567417.81889.4560.7460.040
营业外收支净额/利润总额(%)-224.871-27.057-3.792-0.068-0.192

偿债能力分析
流动比率 (X)15.9544.8352.6983.2485.495
速动比率 (X)15.6144.6692.5713.1394.974
资产负债率 (%)6.1258.71214.81726.34916.594
带息债务/全部投入资本 (%)0.3840.4111.1316.9063.398
股东权益/带息债务 (%)25,616.12423,884.6368,631.6771,336.1842,821.838
股东权益/负债合计 (%)1,488.1101,014.342550.562268.294491.842
利息保障倍数 (X)4.207-2.39227.931-144.295-287.170

营运能力分析
应收账款周转天数 (天)843.3931,014.913905.10256.38058.484
存货周转天数 (天)161.494235.376203.37427.998102.427